IP Agreement Review Agent

Automate the review, interpretation, and risk assessment of IP license agreements for the legal department — helping identify compliance issues, renewal opportunities, and optimization levers.

About the Agent

The IP Agreement Review Agent is a ZBrain-powered solution designed for Legal operations. It automates the review, analysis and risk assessment of intellectual property license agreements by parsing legal documents to identify key clauses, extract obligations, and evaluate compliance with internal policies and regulatory standards. It handles variations in agreement drafting and presents structured, consistent outputs to support legal analysis.


The agent identifies potential legal and compliance risks by flagging missing or non-compliant clauses, such as vague termination terms, undefined royalty structures, or exclusivity provisions that do not meet internal requirements. It compares agreement content against predefined clause libraries and internal legal benchmarks to generate clause-level deviation and risk assessment reports. These insights help ensure that agreement aligns with the organization’s legal standards and IP protection strategy.

It supports ongoing contract oversight by tracking renewal timelines, notice periods, and contractual obligations. Integrated with document repositories and contract lifecycle systems, the agent continuously monitors for new or updated agreements and initiates timely reviews. It produces consistent, explainable outputs, enabling legal teams to scale contract review processes while maintaining accuracy and compliance.

Accuracy
TBD

Speed
TBD

Input Data Set

Sample of data set required for IP Agreement Review Agent:


SOFTWARE LICENSE AGREEMENT

Effective Date: March 15, 2024

Parties:

  • Licensor: TechInnovations Inc., a corporation organized under the laws of Delaware, with its principal office at 123 Innovation Drive, Wilmington, DE 19801.
  • Licensee: GlobalSolutions Corp., a corporation organized under the laws of Delaware, with its principal office at 456 Enterprise Lane, Dover, DE 19904.

1. DEFINITIONS

1.1 "Agreement" means this Software License Agreement, including all exhibits and any amendments.

1.2 "Software" means the proprietary machine-learning analytics platform known as "TI-Analyze AI v3.0," as described in Exhibit A, including all updates, enhancements, bug fixes, and derivative works.

1.3 "Documentation" means user manuals, technical manuals, and other written materials provided by Licensor for use with the Software.

1.4 "Territory" means North America, Europe, and Asia.

1.5 "Net Sales" means gross revenue received from the distribution of the Software, less taxes, returns, and shipping costs.

1.6 "Confidential Information" has the meaning ascribed in Section 9.


2. LICENSE GRANT

2.1 License: Licensor hereby grants to Licensee a non-exclusive, non-transferable, and limited right to use, market, and distribute the Software and Documentation within the Territory (defined as North America, Europe, and Asia).

2.2 Sublicensing: Licensee may not sublicense the Software without Licensor's prior written consent.

2.3 Exclusive Rights: Licensee shall have exclusive distribution rights in the Territory for a period of three (3) years, provided it meets the minimum annual sales threshold of $5,000,000.


3. FEES AND PAYMENTS

3.1 Royalty: Licensee shall pay Licensor seven percent (7%) of Net Sales on a quarterly basis.

3.2 Payment Terms: All payments shall be made within thirty (30) days of the end of each calendar quarter.

3.3 Late Payments: Late payments shall accrue interest at the rate of one and one-half percent (1.5%) per month.

3.4 Audit Rights: Licensor shall have the right to audit Licensee's books and records related to Software sales upon thirty (30) days' prior written notice.


4. MAINTENANCE AND SUPPORT

4.1 Updates: Licensor shall provide updates, upgrades, and patches as made generally available to its licensees.

4.2 Support: Licensor shall provide email-based technical support during standard business hours.


5. INTELLECTUAL PROPERTY

5.1 Ownership: All intellectual property rights in and to the Software and Documentation remain solely with Licensor.

5.2 Restrictions: Licensee shall not modify, reverse engineer, decompile, disassemble, or create derivative works of the Software.


6. CONFIDENTIALITY

6.1 Obligations: Each party agrees to protect the Confidential Information of the other with the same degree of care it uses to protect its own, but no less than reasonable care.

6.2 Exceptions: Confidential Information does not include information that is public, rightfully received from a third party, or independently developed.


7. WARRANTIES AND DISCLAIMERS

7.1 Limited Warranty: Licensor warrants that the Software will perform substantially in accordance with the Documentation for a period of ninety (90) days after delivery.

7.2 Disclaimer: Except as expressly set forth, the software is provided "as is" without warranty of any kind.


8. LIMITATION OF LIABILITY

8.1 In no event shall either party be liable for any indirect, incidental, special, or consequential damages.

8.2 Licensor's total liability under this agreement shall not exceed the amounts paid by licensee during the twelve (12) months prior to the claim.


9. INDEMNIFICATION

9.1 By Licensee: Licensee agrees to indemnify and hold harmless Licensor from any claims arising out of Licensee's misuse of the Software.

9.2 By Licensor: Licensor agrees to indemnify Licensee against claims that the Software infringes any third-party intellectual property rights.


10. TERM AND TERMINATION

10.1 Term: This Agreement shall commence on the Effective Date and remain in effect for three (3) years unless terminated earlier.

10.2 Termination for Convenience: Either party may terminate with ninety (90) days' written notice.

10.3 Termination for Cause: Either party may terminate for material breach not cured within forty-five (45) days of written notice.

10.4 Effect of Termination: Upon termination, Licensee shall cease all use and distribution of the Software and return or destroy all copies.


11. GENERAL

11.1 Governing Law: This Agreement shall be governed by the laws of the State of Delaware.

11.2 Dispute Resolution: Any disputes shall be resolved through binding arbitration in Wilmington, DE.

11.3 Force Majeure: Neither party shall be liable for delays due to causes beyond its reasonable control.

11.4 Notices: All notices shall be in writing and sent to the addresses listed above.

11.5 Entire Agreement: This Agreement, including its exhibits, constitutes the entire agreement and supersedes all prior discussions.

11.6 Amendment: No amendment shall be valid unless in writing and signed by both parties.

11.7 Assignment: Licensee may not assign this Agreement without Licensor's prior written consent.


EXHIBIT A: SOFTWARE DESCRIPTION

  • Product Name: TI-Analyze AI v3.0
  • Functionality: Predictive analytics tool for supply chain optimization.
  • License Key: Activation upon receipt of first royalty payment.

SIGNATURES

LICENSOR: TechInnovations Inc.

Name: John A. Smith
Title: Chief Legal Officer
Date: March 15, 2024
Signature: ___

LICENSEE: GlobalSolutions Corp.

Name: Maria L. Chen
Title: CEO
Date: March 15, 2024
Signature: ___


Deliverable Example

Sample output delivered by the IP Agreement Review Agent:

IP AGREEMENT COMPLIANCE REPORT

TechInnovations Inc. ↔ GlobalSolutions Corp.
Software License Agreement | Effective: March 15, 2024


Executive Summary

Metric Result
Overall Compliance 68% (Target: 85%)
Critical Risks 3
Policy Deviations 5
Recommendation Revise & Resubmit

Clause Analysis

1. License Grant (Section 2.1)

Extract:

"Licensor grants Licensee a non-exclusive, non-transferable license to use, market, and distribute the Software... within the Territory (North America, Europe, and Asia)."

Findings:

  • Non-Compliant
  • Territory exceeds policy limits (North America only per IP-POL-2023-003)
  • Ambiguous "non-transferable" language conflicts with sublicensing allowance (Section 2.2)

Risk: Legal (High) | Operational (Medium)
Action: Restrict Territory to North America; clarify transferability terms


2. Exclusivity Clause (Section 2.3)

Extract:

"Exclusive distribution rights... contingent on $5,000,000 annual sales."

Findings:

  • Partially Compliant
  • 3-year term aligns with IP-POL-2023-004
  • No audit/enforcement mechanism for sales targets
  • Missing cure period for missed thresholds

Risk: Financial (High) | Operational (Medium)
Action: Add quarterly sales audits + 60-day cure period


3. Royalty Structure (Section 3.1)

Extract:

"7% of Net Sales... no annual cap."

Findings:

  • Non-Compliant
  • Rate exceeds 5% cap (IP-POL-2023-002)
  • Missing $2M annual limit

Risk: Financial (Critical)
Action: Reduce rate to 5% + add $2M cap


4. Termination Terms (Section 10.2)

Extract:

"Either party may terminate with ninety (90) days' written notice."

Findings:

  • Moderate Risk
  • 90-day notice exceeds 60-day policy standard
  • Waiver Approved: Legal Dept exception #2024-015

Risk: Operational (Low)


Risk Matrix

Clause Legal Risk Financial Risk Operational Risk
License Grant High Low Medium
Exclusivity Medium High Medium
Royalties Low Critical Low
Termination Low Low Low

Key Deadlines

  1. First Royalty Payment: June 30, 2024
  2. Contract Revision Deadline: April 30, 2024
  3. Renewal Notice Window Opens: December 15, 2026

Recommended Actions

  1. Priority Revisions:
    • Amend Territory definition (Section 2.1)
    • Insert $2M royalty cap (Section 3.1)
    • Add sales audit (Section 3.4 amendment)

Related Agents